Comprehensive Analysis of the 15-Year Carryover Mechanism within the Maine Research Expense Tax Credit Framework
The Maine Research Expense Tax Credit carryover period allows businesses to apply unused credit amounts against their state income tax liability for up to 15 succeeding taxable years. This provision ensures that taxpayers making substantial in-state research investments can realize the full value of the credit even if their current-year tax liability is insufficient to absorb it.
The implementation of the 15-year carryover window serves as a critical fiscal bridge for innovative enterprises operating within Maine’s borders. Established under the Maine Revised Statutes (M.R.S.) Title 36, Section 5219-K, the carryover mechanism acknowledges the inherent volatility and long-term horizons of research and development (R&D) cycles. In many technology-intensive sectors, such as biotechnology, aerospace, and advanced manufacturing, the period between initial investment and the generation of significant taxable income can span a decade or more.1 Without an extended carryover period, the “nonrefundable” nature of the Maine R&D tax credit would render it ineffective for early-stage startups and companies undergoing heavy capital expansion, as the credit cannot reduce a taxpayer’s liability below zero in any single year.2 By providing a 15-year window, the State Tax Assessor and the Maine Legislature have created a stable environment where credits earned during years of intensive experimentation and potential net operating losses are preserved as deferred tax assets.4 This allows the fiscal benefit to “mature” alongside the technological innovations it was designed to incentivize.
Statutory Basis and Legislative Intent of Section 5219-K
The foundational authority for the Maine Research Expense Tax Credit is 36 M.R.S. § 5219-K, which was enacted in 1995 to foster a climate of innovation.6 The statute provides a specific calculation for the credit that is deeply integrated with the federal Internal Revenue Code (IRC) Section 41, yet it is refined by unique state-level constraints and geographical limitations. The credit is available to both corporations and individual taxpayers—including owners of pass-through entities such as S-corporations and Limited Liability Companies (LLCs)—who engage in qualified research within the state.2
The credit itself is composed of two primary components: an incremental credit and a basic research credit. The incremental portion is calculated as 5% of the excess, if any, of the qualified research expenses (QREs) for the taxable year over the base amount.3 The base amount is defined as the average annual QREs incurred over the previous three taxable years.4 Additionally, taxpayers may claim 7.5% of basic research payments made to qualified organizations, such as universities or scientific research institutes, as determined under IRC Section 41(e)(1)(A).1 The legislative intent behind this structure is to incentivize not just research in the abstract, but a sustained increase in research spending over time. By tying the credit to expenditures above a three-year average, the state ensures that taxpayers are rewarded for expanding their innovative capacity rather than simply maintaining existing operations.
Geographical and Definition Nuances
A defining characteristic of the Maine R&D credit is its strict geographical limitation. While it leverages federal definitions for what constitutes “qualified research,” the expenditures only qualify for the Maine credit if the research is conducted within the physical borders of the State of Maine.1 This creates a high evidentiary burden for taxpayers who operate across multiple states, necessitating rigorous cost-segregation and accounting practices to ensure that only Maine-based wages, supplies, and contract research are included in the calculation.3
| Credit Component | Maine Statutory Rate | Federal Baseline Reference | Geographical Limitation |
| Incremental Credit | 5% of Excess over Base | IRC § 41(a)(1) | In-State Only |
| Basic Research Credit | 7.5% of Payments | IRC § 41(e)(1)(A) | In-State Only |
| Carryover Period | 15 Taxable Years | Varies (Typically 20 Years) | Maine Tax Liability Only |
| Refundability | Nonrefundable | Nonrefundable (Except QSB Payroll) | N/A |
1
The Mechanics of the 15-Year Carryover Period
The 15-year carryover period is the most significant flexibility mechanism for the Maine R&D credit. Under 36 M.R.S. § 5219-K(5), any taxpayer entitled to a credit that exceeds the tax due for the taxable year may carry over and apply that portion to the tax due for any one or more of the next succeeding 15 taxable years.4 This carryover applies to the “portion, as reduced from year to year,” indicating that the credits are exhausted in a sequential, chronological fashion.4
The Nonrefundability Constraint and Carryover Necessity
The primary driver for the carryover provision is the nonrefundable status of the credit. Specifically, 36 M.R.S. § 5219-K(2) mandates that the credit allowed for any taxable year may not reduce the tax due to less than zero.3 For many high-growth technology companies, particularly those in the “pre-revenue” or “scale-up” phases, annual expenses often exceed income, leading to a zero or negative tax liability. Without the 15-year carryover, these companies would permanently lose the benefit of the tax credits earned during their most critical research years.6
The 15-year window provides a buffer that accommodates the typical “J-curve” of venture-backed startups, where significant R&D spending occurs years before the company reaches profitability. For example, a biotechnology firm conducting drug trials in Maine might generate $500,000 in R&D credits over five years while recording no taxable income. The 15-year carryover ensures that these credits remain available to offset the significant tax liabilities that may arise once a product is commercialized and begins generating profit in Year 6 or beyond.1
Corporate Utilization Limitations and Carryover Interaction
For corporate taxpayers, the carryover mechanism is further complicated by annual utilization limits. Unlike individual taxpayers, who can generally use the credit to offset their entire liability (down to zero), corporations are subject to a tiered limitation under 36 M.R.S. § 5219-K(3).2 The credit allowed in any single year for a corporation is limited to:
- 100% of the corporation’s first $25,000 of tax due (determined before credits).
- 75% of the corporation’s tax due in excess of $25,000.1
This limitation creates a scenario where a corporation with a very large tax liability can never use its R&D credits to completely eliminate its tax bill. Even if a corporation has $1 million in earned credits and $100,000 in tax liability, it can only use $81,250 of those credits in the current year ($25,000 + 75% of the remaining $75,000).1 The remaining $18,750 of tax must be paid in cash, and the unused portion of the credits ($918,750) must be carried forward to the next year.4 The 15-year carryover period is essential here because it accounts for the fact that large corporations can only chip away at their accumulated credit banks at a rate of 75% of their annual liability over $25,000.
Calculation of the Maine R&D Tax Credit and Base Amount
To understand the carryover, one must first master the calculation of the credit itself. The “incremental” nature of the credit means that it only rewards research spending that exceeds a historical baseline. This baseline is the “base amount,” which is calculated as the average amount spent on QREs in Maine over the previous three taxable years.1
Mathematical Formula for Credit Generation
The total credit earned in a given tax year is represented by the formula:
$$C_{total} = (0.05 \times (QRE_{current} – \text{Base})) + (0.075 \times BP)$$
Where:
- $C_{total}$ is the total Research Expense Tax Credit earned for the year.
- $QRE_{current}$ represents the total qualified research expenses conducted in Maine during the taxable year.1
- $\text{Base}$ is the average of QREs for the three preceding tax years.4
- $BP$ is the amount of basic research payments to qualified organizations.1
If a taxpayer has fewer than three years of prior QREs, the base is the average of whatever years are available. For a brand-new entity with no prior research history, the base is $0, allowing the company to claim a 5% credit on every dollar of its first-year research expenditures.1
Defining Qualified Research Expenses (QREs)
Maine adheres to the federal definition of QREs found in IRC Section 41(b), but it applies these definitions exclusively to Maine-based activities.5 QREs generally include:
- Wages: Salaries and wages paid to employees directly involved in research, including those supervising or supporting research activities.1 According to OPEGA findings, wages typically account for approximately 76% of all QREs claimed.7
- Supplies: Costs for tangible property (other than land or improvements) used in the conduct of qualified research.11
- Contract Research: 65% of amounts paid to third parties for research conducted on the taxpayer’s behalf, provided the research takes place in Maine.1
To qualify as “qualified research,” the activity must satisfy the federal “Four-Part Test” 3:
- Permitted Purpose: The research must be intended to create a new or improve an existing business component (product, process, technique, formula, or invention) in terms of functionality, performance, reliability, or quality.11
- Elimination of Uncertainty: The taxpayer must intend to discover information that would eliminate technical uncertainty regarding the capability, method, or design for developing the business component.3
- Process of Experimentation: The taxpayer must engage in a systematic process of evaluating alternatives, such as modeling, simulation, or trial-and-error, to resolve the uncertainty.11
- Technological in Nature: The research must fundamentally rely on the principles of physical science, biological science, engineering, or computer science.3
Maine Revenue Services (MRS) Guidance and Instructional Bulletins
The administration of the Research Expense Tax Credit is handled by Maine Revenue Services (MRS). MRS provides several resources to assist taxpayers in claiming the credit and tracking carryovers, primarily through instructional bulletins and annual worksheets.5
The Research Expense Tax Credit Worksheet
The 2024 Research Expense Tax Credit Worksheet (Form 36 M.R.S. § 5219-K) is the primary reporting vehicle for this credit.2 Taxpayers must complete this worksheet and attach it to their Maine income tax return (e.g., Form 1120ME for corporations or Form 1040ME for individuals).11
Key lines on the worksheet for carryover tracking include:
- Line 1 & 2: Calculation of basic research payment credits.2
- Line 3-6: Calculation of incremental QRE credits, including the base amount subtraction.2
- Line 7: “Enter the unused credit amounts from prior years.” This is the critical line where the 15-year carryover is captured and added to the current year’s generation.2
- Line 8: Calculation of the credit limitation for the current year. Any amount from Line 8 that remains unused because of the tax liability limit or the 75% corporate cap is then carried forward to the following year’s Line 7.2
Instructional Bulletin No. 54 and Sales Tax Context
While the Research Expense Tax Credit is an income tax credit, MRS also issues bulletins for other tax types that provide insight into the agency’s general administrative philosophy. For example, Instructional Bulletin No. 54 (“Resale Certificates”) and Bulletin No. 36 (“Maine Fishery Infrastructure Tax Credit”) emphasize the importance of documentation and the “good faith” requirement for claiming exemptions and credits.15 MRS requires taxpayers to maintain records supporting their R&D claims for at least six years, but given the 15-year carryover period, it is standard professional advice to maintain these records for as long as the credit remains in the carryover pool.1
| MRS Guidance Document | Relevant Tax Type | Key Insight for R&D Claimants |
| Schedule 5219-K Worksheet | Corporate/Individual Income | Direct form for calculating 15-year carryover |
| Rule 801 (Apportionment) | Corporate Income | Crucial for multi-state businesses tracking Maine QREs |
| Instructional Bulletin No. 22 | Sales/Use Tax | Defines “Production” for manufacturers claiming R&D |
| Form 1120ME Instructions | Corporate Income | Details the tiered 100% / 75% credit limitations |
4
Comprehensive Multi-Year Example: “Northern Biotech, Inc.”
To illustrate how the 15-year carryover period and corporate limitations function in practice, consider the case of Northern Biotech, Inc., a Maine-based C corporation.
Year 1: Intensive R&D, No Liability
In Year 1, Northern Biotech spends $1,000,000 on qualified research in Maine. As a new company, its base amount is $0.
- Credit Earned: $1,000,000 \times 0.05 = $50,000.
- Tax Liability: $0 (the company is in a loss position).
- Credit Used: $0.
- Carryover to Year 2: $50,000 (Expiration: Year 16).1
Year 2: Sustained R&D, Initial Profits
In Year 2, the company spends another $1,000,000 on QREs. Its new base amount is the Year 1 expenditure divided by 1, or $1,000,000.
- Current Credit Earned: ($1,000,000 – $1,000,000) \times 0.05 = $0.
- Tax Liability: $10,000.
- Total Available Credit: $0 (current) + $50,000 (carryover) = $50,000.
- Corporate Limitation: Since liability is < $25,000, the limit is 100% of tax, which is $10,000.2
- Credit Used: $10,000.
- Remaining Carryover to Year 3: $40,000 (Expiration: Year 16).4
Year 3: Scaling R&D and Revenue
In Year 3, the company expands, spending $1,500,000 on QREs. The base amount is the average of Years 1 and 2: ($1,000,000 + $1,000,000) / 2 = $1,000,000.
- Current Credit Earned: ($1,500,000 – $1,000,000) \times 0.05 = $25,000.
- Tax Liability: $100,000.
- Total Available Credit: $25,000 (current) + $40,000 (carryover) = $65,000.
- Corporate Limitation Calculation:
- 100% of first $25,000 = $25,000.
- 75% of remaining $75,000 = $56,250.
- Total Max Allowed: $25,000 + $56,250 = $81,250.1
- Credit Used: $65,000 (since $65,000 < $81,250, the entire amount is used).
- Remaining Carryover: $0.
Summary of Credit Life Cycle
| Year | QREs | Base Amount | Credit Earned | Carryover Used | Total Credit | Tax Liability | Final Tax Paid | Carryforward |
| Year 1 | $1,000,000 | $0 | $50,000 | $0 | $50,000 | $0 | $0 | $50,000 |
| Year 2 | $1,000,000 | $1,000,000 | $0 | $10,000 | $10,000 | $10,000 | $0 | $40,000 |
| Year 3 | $1,500,000 | $1,000,000 | $25,000 | $40,000 | $65,000 | $100,000 | $35,000 | $0 |
1
Pass-Through Treatment and Individual Carryover
For business entities that do not pay income tax at the entity level—such as S-corporations, Partnerships, and LLCs—the Research Expense Tax Credit flows through to the owners.1 The credit is allocated to each partner or shareholder in proportion to their ownership interest in the entity during the tax year.2
Individual owners then claim the credit on their Maine personal income tax return (Form 1040ME) using the same 5219-K worksheet.2 For these individual taxpayers, the $25,000 corporate limitation does not apply. Instead, the credit is limited only by the individual’s total tax liability for the year.1 Any excess credit earned by the individual via the pass-through entity is subject to the same 15-year carryover period.1 This pass-through mechanic is vital for Maine’s small-to-medium-sized technology firms, as it allows the owners to offset their personal tax liabilities with the company’s research investments, thereby increasing the effective capital available for further R&D.
Historical Comparison: The “Super Credit” (§ 5219-L)
Taxpayers analyzing Maine’s R&D landscape often encounter references to the “Super Credit for Substantially Increased Research and Development” under Section 5219-L.5 It is critical to distinguish this from the regular Section 5219-K credit, as the Super Credit has different carryover rules and is largely historical in nature.
The Super Credit was designed to reward massive expansions in R&D capacity. It offered a credit for QREs that exceeded a “super credit base amount,” which was defined as the average QREs from the three years prior to 1997, increased by 50%.22 However, the Super Credit was repealed for tax years beginning on or after January 1, 2014.7
Key Differences in Carryover and Limits
The Super Credit featured a more restrictive carryover period and tighter utilization caps than the regular R&D credit:
- Carryover Period: Historically 10 years, though some legislative modifications restricted it further to 5 years for certain periods.8
- Utilization Limit: The Super Credit was limited to 50% of the taxpayer’s tax due after other credits.8
- Baseline Restriction: It could not be used to reduce tax liability below the amount of tax due in the preceding taxable year.8
For 2024 and 2025 tax filings, the Super Credit is only relevant to taxpayers who generated significant credits before 2014 and are still within their 10-year carryover window (e.g., a credit generated in 2013 would potentially expire in 2023 or 2024).22 All new research activity in Maine must be claimed under the Section 5219-K regular credit with its superior 15-year carryover.1
Statistical Overview and OPEGA Evaluation
The Office of Program Evaluation and Government Accountability (OPEGA) conducted a formal review of the Research Expense Tax Credit in 2021, providing a data-driven look at how the credit and its carryover provisions have performed.6
Utilization and Economic Impact
OPEGA’s findings highlight a complex relationship between the tax incentive and Maine’s economic growth. While the credit has been available since 1995 and features a generous 15-year carryover, Maine has historically performed poorly in R&D measures compared to other states.6
- Claim Volume: Historical annual claims for the R&D credit typically range between $2 million and $4 million.1
- State Performance: Data from the National Science Foundation (NSF) indicated that Maine lags in R&D as a percentage of GDP, despite having an R&D credit like 70% of other U.S. states.6
- Exclusion of Businesses: OPEGA found that the incremental structure (requiring a 3-year increase) and the nonrefundable nature of the credit actually exclude many businesses conducting R&D from seeing an immediate benefit. This reinforces the necessity of the 15-year carryover, as it is the only way these businesses can eventually capture the credit’s value.6
OPEGA Recommendations and Data Gaps
A significant portion of the OPEGA report focused on the difficulty of tracking the credit’s effectiveness. Because Maine Revenue Services is only responsible for the processing of tax returns and does not have a statutory mandate to collect long-term performance data, the state has “limited” ability to understand the specific economic impacts of the credit.6
OPEGA made three primary recommendations for the Maine Legislature:
- Clarify Goals: Formally memorialize the intended beneficiaries and success metrics for the credit.6
- Amend Design: Modify the credit to ensure that intended beneficiaries, such as those with low current tax liability, can more easily access the incentive (potentially through refundability or different base calculations).6
- Mandate Data Collection: Require the collection of better data to allow for effective oversight of the program’s ROI.6
Future Outlook: The Dirigo Business Incentives Program (2025)
Starting on January 1, 2025, Maine’s business incentive landscape will undergo a major transformation with the launch of the Dirigo Business Incentives program.26 While the Research Expense Tax Credit under Section 5219-K remains in place, the new Dirigo program will replace other historical incentives like the Pine Tree Development Zone (PTDZ) credits and the Maine Capital Investment Credit (MCIC).28
Dirigo vs. R&D Credit: Strategic Choice
The Dirigo program offers a 5% to 10% capital investment tax credit and a $2,000-per-employee training credit for businesses in specific sectors, including “engineering, architecture, and scientific research and development services”.27
For R&D-heavy firms, the Dirigo program presents a different value proposition than the 15-year carryover of the regular R&D credit:
- Refundability: The Dirigo credit is refundable up to $500,000 per year, providing immediate cash flow to companies even if they have zero tax liability.26
- Carryover: The Dirigo carryover period is only 4 years, much shorter than the 15-year window of Section 5219-K.27
- Eligibility: To claim Dirigo, businesses must apply to the Department of Economic and Community Development (DECD) and receive a letter of certification before beginning their investment.29 The Research Expense Tax Credit, by contrast, is claimed directly on the tax return based on actual spending without prior certification.1
| Feature | Research Expense Credit (§ 5219-K) | Dirigo Business Incentives (2025) |
| Carryover Period | 15 Years | 4 Years |
| Annual Limit | Tiered (100% / 75%) for Corps | $2,000,000 per taxpayer |
| Refundable Cap | $0 (Nonrefundable) | $500,000 per tax year |
| Certification | Self-reported on tax return | Prior DECD Certification Required |
1
Companies will need to evaluate their multi-year tax projections to decide which incentive path is more beneficial. A company expecting a long path to profitability may still find the 15-year carryover of the R&D credit more valuable, while a company needing immediate capital for training or equipment might prefer the Dirigo program’s refundability.28
Compliance and Audit Preparedness
Given the 15-year lifecycle of the Maine R&D tax credit, audit preparedness is a long-term obligation. Maine Revenue Services has the authority to verify that the QREs claimed in the current year—as well as those used to calculate the base amount from three years prior—are accurate.1
Documentation Best Practices
Taxpayers must provide a copy of their federal Form 6765 with their Maine filing to support the state-level claim.2 Furthermore, because the Maine credit is strictly for in-state research, documentation must clearly separate Maine-based expenses from any multi-state or international activities.1
Key items to retain for the full 15-year carryover period include:
- Project Lists: A comprehensive catalog of all research projects claimed each year.11
- Wage Documentation: Payroll records that link specific employees to research projects, ideally supported by time-tracking software.1
- Supply Invoices: Receipts for materials consumed during the research process, ensuring they were used for “experimental” purposes.11
- Contractual Agreements: Copies of all contracts for research conducted by third parties in Maine, proving the taxpayer bore the financial risk and retained the intellectual property rights.1
Unitary Groups and Combined Returns
For corporations filing as part of a unitary group, the carryover tracking becomes even more critical. Maine law requires that credits generated by an individual member corporation must first be applied against that specific member’s portion of the group’s tax liability.4 If there is an excess, it can be shared with other members, but the underlying “ownership” of the credit and its 15-year expiration clock remain tied to the generating entity.4 In the event of a corporate spin-off or sale, accurately tracking which entity “owns” which year’s carryover is a complex but necessary task for tax compliance.4
Conclusion
The 15-year carryover period for the Maine Research Expense Tax Credit stands as a pillar of the state’s industrial policy, specifically engineered to support the extended timelines inherent in scientific discovery and technological innovation. By providing a decade and a half for businesses to utilize their earned credits, the Maine Revised Statutes accommodate the unique financial pressures of high-growth, technology-intensive sectors.
While the 15-year window is generous, it is not without its limitations. The nonrefundable nature of the credit and the tiered utilization caps for corporations—limiting claims to 100% of the first $25,000 and 75% thereafter—ensure that the credit remains an incremental incentive rather than a complete tax holiday. Furthermore, as the state pivots toward the Dirigo Business Incentives in 2025, taxpayers must remain vigilant in their strategic planning, balancing the long-term carryover potential of Section 5219-K against the more immediate, but shorter-lived, refundable benefits of the new program. For the foreseeable future, the 15-year carryover remains a vital mechanism for ensuring that today’s investments in Maine-based research can provide a fiscal foundation for tomorrow’s commercial success.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










